Manitou Investment Management Ltd. Has $16,190,000 Stake in CME Group Inc. (CME)
Manitou Investment Management Ltd. increased its position in CME Group Inc. (NASDAQ:CME) by 33.8% during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 166,221 shares of the company’s stock after buying an additional 42,010 shares during the period. CME Group accounts for about 5.1% of Manitou Investment Management Ltd.’s holdings, making the stock its 4th largest position. Manitou Investment Management Ltd.’s holdings in CME Group were worth $16,190,000 as of its most recent SEC filing.
Other hedge funds also recently added to or reduced their stakes in the company. Sumitomo Mitsui Trust Holdings Inc. boosted its position in shares of CME Group by 4.6% in the second quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 1,137,234 shares of the company’s stock worth $110,767,000 after buying an additional 50,334 shares during the last quarter. Quantitative Systematic Strategies LLC acquired a new position in shares of CME Group during the second quarter worth approximately $1,027,000. ING Groep NV boosted its position in shares of CME Group by 185.7% in the second quarter. ING Groep NV now owns 19,716 shares of the company’s stock worth $1,920,000 after buying an additional 12,814 shares during the last quarter. Tokio Marine Asset Management Co. Ltd. boosted its position in shares of CME Group by 17.2% in the second quarter. Tokio Marine Asset Management Co. Ltd. now owns 27,578 shares of the company’s stock worth $2,686,000 after buying an additional 4,042 shares during the last quarter. Finally, Capital Fund Management S.A. boosted its position in shares of CME Group by 3.1% in the second quarter. Capital Fund Management S.A. now owns 64,514 shares of the company’s stock worth $6,284,000 after buying an additional 1,910 shares during the last quarter. 79.89% of the stock is currently owned by institutional investors.
Shares of CME Group Inc. (NASDAQ:CME) traded up 0.35% on Tuesday, reaching $104.09. 637,943 shares of the company traded hands. CME Group Inc. has a 52-week low of $81.87 and a 52-week high of $110.35. The company has a market capitalization of $35.27 billion, a PE ratio of 26.29 and a beta of 0.83. The firm has a 50-day moving average of $106.42 and a 200-day moving average of $99.82.
CME Group (NASDAQ:CME) last issued its earnings results on Thursday, July 28th. The company reported $1.14 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.11 by $0.03. CME Group had a return on equity of 6.83% and a net margin of 38.22%. The firm had revenue of $906 million for the quarter, compared to analyst estimates of $897.84 million. During the same period last year, the company earned $0.95 earnings per share. The firm’s revenue for the quarter was up 10.5% on a year-over-year basis. On average, equities research analysts forecast that CME Group Inc. will post $4.43 earnings per share for the current fiscal year.
The business also recently announced a quarterly dividend, which was paid on Monday, September 26th. Shareholders of record on Friday, September 9th were given a $0.60 dividend. This represents a $2.40 annualized dividend and a yield of 2.31%. The ex-dividend date of this dividend was Wednesday, September 7th. CME Group’s dividend payout ratio is presently 60.61%.
A number of equities analysts have recently commented on the stock. Deutsche Bank AG lifted their target price on shares of CME Group from $110.00 to $111.00 and gave the company a “buy” rating in a report on Friday, July 29th. JPMorgan Chase & Co. lifted their price objective on shares of CME Group from $99.00 to $106.00 and gave the company an “overweight” rating in a research report on Friday, July 29th. Barclays PLC lowered their price objective on shares of CME Group from $100.00 to $99.00 and set an “equal weight” rating on the stock in a research report on Friday, July 29th. Zacks Investment Research upgraded shares of CME Group from a “sell” rating to a “hold” rating in a research report on Thursday, June 30th. Finally, Keefe, Bruyette & Woods lifted their price objective on shares of CME Group from $99.00 to $103.00 and gave the company a “market perform” rating in a research report on Friday, July 29th. Two research analysts have rated the stock with a sell rating, six have issued a hold rating and five have given a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and a consensus price target of $103.27.
In other news, insider Kimberly S. Taylor sold 2,300 shares of the firm’s stock in a transaction on Monday, August 1st. The stock was sold at an average price of $102.58, for a total transaction of $235,934.00. Following the transaction, the insider now directly owns 103,789 shares of the company’s stock, valued at $10,646,675.62. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Phupinder Gill sold 20,080 shares of the firm’s stock in a transaction on Monday, August 15th. The shares were sold at an average price of $104.54, for a total value of $2,099,163.20. Following the transaction, the chief executive officer now directly owns 154,141 shares in the company, valued at $16,113,900.14. The disclosure for this sale can be found here. 0.61% of the stock is owned by company insiders.
About CME Group
CME Group Inc is a provider of products across all major asset classes, based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals. The Company’s products include both exchange-traded and privately negotiated futures and options contracts and swaps. The Company connects buyers and sellers together through its CME Globex electronic trading platform across the globe and its open outcry trading facilities in Chicago and New York City.
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME).
Receive News & Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.